Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick T Murray

Showing results (81-90 of 120) with videos related to

Pageof 12
Sort By:
Kidney International Reports|November 17, 2017
Rationale and Design of the Genetic Contribution to Drug Induced Renal Injury (DIRECT) StudyLinda Awdishu, Caroline M Nievergelt, Andrew Davenport, et al.
Nephron|September 13, 2021
Clinical Implementation and Initial Experience of Neutrophil Gelatinase-Associated Lipocalin Testing for the Diagnostic and Prognostic Assessment of Acute Kidney Injury Events in Hospitalized PatientsJean-Maxime Côté, Liam Lyons, Patrick J Twomey, et al.
Critical Care (London, England)|November 10, 2023
Moving toward a contemporary classification of drug-induced kidney diseaseIman Karimzadeh, Erin F Barreto, John A Kellum, et al.
Kidney International|July 25, 2008
Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgeryJay L Koyner, Michael R Bennett, Elaine M Worcester, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 28, 2010
Urinary biomarkers in the clinical prognosis and early detection of acute kidney injuryJay L Koyner, Vishal S Vaidya, Michael R Bennett, et al.
Journal of Cardiology|February 1, 2025
Racial differences in diuretic therapy, B-type natriuretic peptide values, and prognosis in acute heart failureYu Horiuchi, Yuya Matsue, Nicholas Wettersten, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 2, 2021
EDTAKI: a Nephrology and Public Policy Committee platform call for more European involvement in acute kidney injuryRaymond Vanholder, Eric Rondeau, Hans-Joachim Anders, et al.
The Journal of Applied Laboratory Medicine|February 27, 2021
Proenkephalin (PENK) as a Novel Biomarker for Kidney FunctionRemi Beunders, Joachim Struck, Alan H B Wu, et al.
Trials|May 30, 2025
A phase 3 study of ravulizumab to protect patients with chronic kidney disease from cardiac surgery-associated acute kidney injury and major adverse kidney events (ARTEMIS)Marlies Ostermann, David C Corteville, Kent Doi, et al.
Cardiovascular Research|September 1, 2021
Diseases of the Aorta and Kidney Disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferencePantelis Sarafidis, Sven Martens, Athanasios Saratzis, et al.
Pageof 12

Showing results (81-90 of 120) with videos related to

Sort By:
Pageof 12
Kidney International Reports|November 17, 2017
Rationale and Design of the Genetic Contribution to Drug Induced Renal Injury (DIRECT) StudyLinda Awdishu, Caroline M Nievergelt, Andrew Davenport, et al.
Nephron|September 13, 2021
Clinical Implementation and Initial Experience of Neutrophil Gelatinase-Associated Lipocalin Testing for the Diagnostic and Prognostic Assessment of Acute Kidney Injury Events in Hospitalized PatientsJean-Maxime Côté, Liam Lyons, Patrick J Twomey, et al.
Critical Care (London, England)|November 10, 2023
Moving toward a contemporary classification of drug-induced kidney diseaseIman Karimzadeh, Erin F Barreto, John A Kellum, et al.
Kidney International|July 25, 2008
Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgeryJay L Koyner, Michael R Bennett, Elaine M Worcester, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 28, 2010
Urinary biomarkers in the clinical prognosis and early detection of acute kidney injuryJay L Koyner, Vishal S Vaidya, Michael R Bennett, et al.
Journal of Cardiology|February 1, 2025
Racial differences in diuretic therapy, B-type natriuretic peptide values, and prognosis in acute heart failureYu Horiuchi, Yuya Matsue, Nicholas Wettersten, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 2, 2021
EDTAKI: a Nephrology and Public Policy Committee platform call for more European involvement in acute kidney injuryRaymond Vanholder, Eric Rondeau, Hans-Joachim Anders, et al.
The Journal of Applied Laboratory Medicine|February 27, 2021
Proenkephalin (PENK) as a Novel Biomarker for Kidney FunctionRemi Beunders, Joachim Struck, Alan H B Wu, et al.
Trials|May 30, 2025
A phase 3 study of ravulizumab to protect patients with chronic kidney disease from cardiac surgery-associated acute kidney injury and major adverse kidney events (ARTEMIS)Marlies Ostermann, David C Corteville, Kent Doi, et al.
Cardiovascular Research|September 1, 2021
Diseases of the Aorta and Kidney Disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferencePantelis Sarafidis, Sven Martens, Athanasios Saratzis, et al.
Pageof 12